Select country change
Shopping cart (0 , 0,00 ) Menu Search
Manufactured by BioVendor

Interleukin-7 Human ELISA

  • Regulatory status:RUO
  • Type:Sandwich ELISA, Biotin-labelled antibody
  • Other names:IL-7, Lymphopoietin-1, pre-B-cell growth factor
  • Species:Human
Please select your region to see available products and prices.
Cat. No. Size Price

RGP014R 96 wells (1 kit)
PubMed Product Details
Technical Data


Sandwich ELISA, Biotin-labelled antibody


Serum, Plasma, Cell culture supernatant

Sample Requirements

100 µl/well


At ambient temperature. Upon receipt, store the product at the temperature recommended below.


Store the complete kit at 2–8°C. Under these conditions, the kit is stable until the expiration date (see label on the box).

Calibration Curve

Calibration Range

6.25–200 pg/ml

Limit of Detection

< 3 pg/ml


Research topic

Cytokines and chemokines and related molecules, Oncology


Interleukin-7 (IL-7) is a pleiotropic cytokine with a variety of activities. IL-7 supports differentiation of cytotoxic T-lymphocytes and promotes the generation of lymphokine-activated killer-cells. IL-7 is further responsible for the upregulation of the production of pro-inflammatory cytokines and the stimulation of the tumoricidal activity of monocytes/macrop­hages.

Product References (6)


  • Churchman SM, Ponchel F. Interleukin-7 in rheumatoid arthritis. Rheumatology(Oxford). 2008 Jun;47(6):753-9. doi: 10.1093/rheumatology/ken053. Epub 2008 Mar20. Review. PubMed PMID: 18356170. See more on PubMed
  • Kang I, Hong MS, Nolasco H, Park SH, Dan JM, Choi JY, Craft J. Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cellresponses to influenza vaccine. J Immunol. 2004 Jul 1;173(1):673-81. PubMed PMID:15210831. See more on PubMed
  • Sereti I, Dunham RM, Spritzler J, Aga E, Proschan MA, Medvik K, Battaglia CA, Landay AL, Pahwa S, Fischl MA, Asmuth DM, Tenorio AR, Altman JD, Fox L, Moir S,Malaspina A, Morre M, Buffet R, Silvestri G, Lederman MM; ACTG 5214 Study Team.IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection.Blood. 2009 Jun 18;113(25):6304-14. doi: 10.1182/blood-2008-10-186601. Epub 2009 Apr 20. PubMed PMID: 19380868; PubMed Central PMCID: PMC2710926. See more on PubMed
  • Sportès C, Babb RR, Krumlauf MC, Hakim FT, Steinberg SM, Chow CK, Brown MR,Fleisher TA, Noel P, Maric I, Stetler-Stevenson M, Engel J, Buffet R, Morre M,Amato RJ, Pecora A, Mackall CL, Gress RE. Phase I study of recombinant humaninterleukin-7 administration in subjects with refractory malignancy. Clin Cancer Res. 2010 Jan 15;16(2):727-35. doi: 10.1158/1078-0432.CCR-09-1303. Epub 2010 Jan 12. PubMed PMID: 20068111; PubMed Central PMCID: PMC2808195. See more on PubMed
  • van Roon JA, Glaudemans KA, Bijlsma JW, Lafeber FP. Interleukin 7 stimulatestumour necrosis factor alpha and Th1 cytokine production in joints of patientswith rheumatoid arthritis. Ann Rheum Dis. 2003 Feb;62(2):113-9. PubMed PMID:12525379; PubMed Central PMCID: PMC1754424. See more on PubMed
  • van Roon JA, Hartgring SA, Wenting-van Wijk M, Jacobs KM, Tak PP, Bijlsma JW, Lafeber FP. Persistence of interleukin 7 activity and levels on tumour necrosisfactor alpha blockade in patients with rheumatoid arthritis. Ann Rheum Dis. 2007 May;66(5):664-9. Epub 2006 Dec 21. PubMed PMID: 17185327; PubMed Central PMCID:PMC1954618. See more on PubMed
Related Products Docs